Leukapheresis products in multiple myeloma: Lower tumor load after mobilization with cyclophosphamide plus G-CSF compared to G-CSF in steady-state.

被引:0
|
作者
Cremer, FW [1 ]
Kiel, K [1 ]
Wallmeier, M [1 ]
Haas, R [1 ]
Goldschmidt, H [1 ]
Moos, M [1 ]
机构
[1] UNIV HEIDELBERG,DEPT INTERNAL MED 5,D-6900 HEIDELBERG,GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:435 / 435
页数:1
相关论文
共 50 条
  • [21] Vinorelbine and cyclophosphamide plus G-CSF as mobilisation regimen for patients with multiple myeloma
    Palmieri, S
    Pocali, B
    Copia, C
    Schiavone, EM
    Annunziata, M
    Viola, A
    Ferrara, F
    BONE MARROW TRANSPLANTATION, 2004, 33 : S354 - S354
  • [22] RESPONSE TO INDUCTION TREATMENT ADAPTED SELECTION OF MOBILIZATION REGIMEN IN MULTIPLE MYELOMA: THE G-CSF ALONE VERSUS HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF REGIMEN
    Lee, J. Y.
    Kim, S. J.
    Jang, J. E.
    Suh, C.
    Lee, H.
    Yhim, H. Y.
    Lee, W. S.
    Min, C. K.
    Lee, J. H.
    Kim, J. S.
    HAEMATOLOGICA, 2014, 99 : 647 - 648
  • [23] Comparing Cyclophosphamide with G-CSF and Plerixafor with G-CSF As Stem Cell Mobilization (SCM) Regimens for Multiple Myeloma (MM) Patients: An Evaluation of Mobilization Efficacy and Toxicity
    Tan, Carlyn Rose C.
    Pancari, Philip A.
    Ulicny, John
    Martin, Mary Ellen
    Barta, Stefan Klaus
    Kropf, Patricia Lamont
    Fung, Henry C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S136 - S136
  • [24] RESPONSE TO INDUCTION TREATMENT ADAPTED SELECTION OF MOBILIZATION REGIMEN IN MULTIPLE MYELOMA: THE G-CSF ALONE VERSUS HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF REGIMEN
    Jungyeon, L.
    Jeong, K. Soo
    Eun, J. Ji
    Chelwon, S.
    Hyewon, L.
    Ho-Young, Y.
    Sik, L. Won
    Chang-Ki, M.
    Hoon, L. Jae
    Seok, K. Jin
    BONE MARROW TRANSPLANTATION, 2014, 49 : S525 - S526
  • [25] A Randomized Comparison of Low-Dose Cyclophosphamide plus G-CSF Versus G-CSF Alone Mobilization after Lenalidomide-Bortezomib-Dexamethasone (RVD) Induction in Multiple Myeloma
    Silvennoinen, Raija
    Lundan, Tuija
    Anttila, Pekka
    Heiskanen, Jouni
    Saily, Marjaana
    Siitonen, Timo
    Kakko, Sakari
    Ollikainen, Hanna
    Vanhatalo, Seppo
    Putkonen, Mervi
    Terava, Venla
    Kutila, Anu
    Partio, Mari
    Launonen, Kirsi
    Rasanen, Anu
    Sikio, Anu
    Suominen, Merja
    Bazia, Piotr
    Kananen, Kristiina
    Kuittinen, Taru
    Porkka, Kimmo
    Remes, Kari
    Jantunen, Esa
    BLOOD, 2014, 124 (21)
  • [26] Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children (vol 2016, 4078215, 2016)
    Vazquez Meraz, Jose Eugenio
    Arellano-Galindo, Jose
    Martinez Avalos, Armando
    Mendoza-Garcia, Emma
    Jimenez-Hernandez, Elva
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [27] The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma
    Rees, Matthew J.
    Panigrahi, Ashish
    Harrison, Simon J.
    Spencer, Andrew
    Khong, Tiffany
    Gibbs, Simon
    Hocking, Jay
    Grigg, Andrew
    Zantomio, Daniela
    BONE MARROW TRANSPLANTATION, 2022, 57 (06) : 1001 - 1003
  • [28] The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma
    Matthew J. Rees
    Ashish Panigrahi
    Simon J. Harrison
    Andrew Spencer
    Tiffany Khong
    Simon Gibbs
    Jay Hocking
    Andrew Grigg
    Daniela Zantomio
    Bone Marrow Transplantation, 2022, 57 : 1001 - 1003
  • [29] Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma
    Chua, Chong Chyn
    Lim, Hui Yin
    Chai, Khai Li
    Ong, Jeremy
    Sim, Shirlene
    Wood, Colin
    Dickinson, Michael
    Campbell, Philip
    Hempton, Jennifer
    King, Hayley
    Dowsing, Claire
    Bergin, Krystal
    Muir, Sharon
    Gibbs, Simon
    Grigg, Andrew
    BONE MARROW TRANSPLANTATION, 2018, 53 (09) : 1116 - 1123
  • [30] Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma
    Chong Chyn Chua
    Hui Yin Lim
    Khai Li Chai
    Jeremy Ong
    Shirlene Sim
    Colin Wood
    Michael Dickinson
    Philip Campbell
    Jennifer Hempton
    Hayley King
    Claire Dowsing
    Krystal Bergin
    Sharon Muir
    Simon Gibbs
    Andrew Grigg
    Bone Marrow Transplantation, 2018, 53 : 1116 - 1123